10-11463112-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014688.5(USP6NL):āc.1816A>Gā(p.Lys606Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000041 in 1,461,684 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014688.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USP6NL | NM_014688.5 | c.1816A>G | p.Lys606Glu | missense_variant | 15/15 | ENST00000609104.6 | NP_055503.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USP6NL | ENST00000609104.6 | c.1816A>G | p.Lys606Glu | missense_variant | 15/15 | 1 | NM_014688.5 | ENSP00000476462 | P1 | |
USP6NL | ENST00000379237.6 | c.1885A>G | p.Lys629Glu | missense_variant | 14/14 | 5 | ENSP00000368539 | |||
USP6NL | ENST00000277575.5 | c.1867A>G | p.Lys623Glu | missense_variant | 14/14 | 5 | ENSP00000277575 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 248878Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135068
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461684Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727120
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 06, 2023 | The c.1867A>G (p.K623E) alteration is located in exon 14 (coding exon 14) of the USP6NL gene. This alteration results from a A to G substitution at nucleotide position 1867, causing the lysine (K) at amino acid position 623 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at